Keyphrases
Status Epilepticus
100%
Valproic Acid
67%
Epilepsy
67%
Oxidative Stress
64%
Valnoctamide
45%
Pharmacokinetic Analysis
42%
Anticonvulsant
40%
Rat Model
39%
Seizure
36%
Butyl
35%
Stereoisomers
30%
Reactive Oxygen Species
30%
Reactive Oxygen Species Production
25%
Acquired Epilepsy
25%
CNS-active
24%
Neuroprotective
24%
Disease Outcome
24%
NADPH Oxidase 2 (NOX2)
24%
Nuclear Factor Erythroid 2-related Factor 2 (Nrf2)
23%
Epileptogenesis
22%
Hippocampus
20%
Seizure Models
19%
Hippocampal Neurons
19%
Temporal Lobe Epilepsy Model
17%
Chronic Epilepsy
17%
Epileptic Seizure
16%
Stereoselectivity
16%
Topiramate
16%
Once-daily
16%
Gene Therapy
16%
Neuronal Death
15%
Antiepileptic Drugs
15%
Acute Symptomatic Seizures
15%
Temporal Lobe Epilepsy
15%
Seizure-like Activity
15%
NADPH Oxidase 4 (NOX4)
14%
Cortex
14%
NADPH Oxidase
14%
Organophosphate
13%
Astrocytes
13%
Cell-type-specific Gene Expression
12%
Antioxidant Therapy
12%
High Mobility Group Box 1 (HMGB1)
12%
Amide Derivatives
12%
Neuronal Damage
12%
Electrical Status Epilepticus
11%
Spontaneous Seizures
11%
Constitutional Isomers
10%
Antiseizure
10%
Pentylenetetrazole
10%
Neuroscience
Status Epilepticus
79%
Reactive Oxygen Species
62%
Oxidative Stress
61%
Transcription Factor Nrf2
42%
Temporal Lobe Epilepsy
33%
Antioxidant
30%
Neuroprotective Agent
28%
Hippocampus
24%
In Vitro
23%
Neuronal Cell Death
23%
NADPH Oxidase
20%
Anticonvulsant
18%
In Vivo
17%
Epileptogenesis
17%
Epileptic Seizure
16%
Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase 2
16%
Valproic Acid
15%
Astrocyte
14%
Cerebrovascular Accident
14%
Pentylenetetrazol
13%
Pilocarpine
11%
Carboxamide
11%
Organophosphate
10%
Pharmacokinetic
9%
Sulforaphane
9%
Kainic Acid
9%
Intractable Epilepsy
8%
Potassium Channel Kv1.1
8%
2,5-Dimethoxy-4-iodoamphetamine
8%
Lentivirus Vector
8%
Neuronal Excitability
8%
Potassium Channel
8%
Endocannabinoid System
8%
Focal Epilepsy
8%
Interneuron
8%
Receptor Potential
8%
Cannabidiol
8%
HMGB1
8%
Promoter Region
8%
Alanine
8%
Nuclear Factor
8%
Kelch Like ECH Associated Protein 1
8%
Tonic-Clonic Seizure
8%
Autoantibody
8%
Immunoglobulin G
8%
Receptor
8%
Glutamate Receptor
8%
Eicosanoid Receptor
8%
Status Epilepticus Model
7%
Excitability
6%
Pharmacology, Toxicology and Pharmaceutical Science
Epileptic State
90%
Pharmacokinetic
61%
Sodium Valproate
59%
Valnoctamide
46%
Diseases
35%
Reactive Oxygen Metabolite
34%
Pharmacodynamics
34%
Epileptogenesis
26%
Anticonvulsive Agent
25%
Rat Model
25%
Transcription Factor Nrf2
23%
Anticonvulsant Activity
22%
Antioxidant
19%
Topiramate
16%
Carboxamide
15%
Organophosphate
14%
Pilocarpine
12%
Placebo
12%
Valpromide
11%
Pentetrazole
10%
Drug Resistant Epilepsy
10%
Neuroprotective Agent
9%
Valproic Acid Derivative
8%
Neural Tube Defect
8%
Paraoxon
8%
Fumaric Acid Dimethyl Ester
8%
Carbamic Acid
8%
Focal Epilepsy
8%
Carbamic Acid Derivative
8%
Nuclear Factor
8%
Deanol
8%
Repurposing
8%
Potassium Channel
8%
Lentivirus Vector
8%
Risperidone
8%
Cerebrovascular Accident
8%
Kelch Like ECH Associated Protein 1
8%
Nervous System Inflammation
8%
Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase 2
8%
Seizure Susceptibility
8%
Teratogenicity
6%
Soman
6%
Combination Drug
6%
Cytotoxicity
5%
Hippocampal Sclerosis
5%
Combination Therapy
5%
Benzodiazepine
5%
Temporal Lobe Epilepsy
5%
